Skip to main content

Advertisement

Log in

A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?

  • Case Report
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

We report the case of a 42-year-old woman with chronic hepatitis C (genotype 1), who in June 2004 started therapy with pegylated interferon alpha (PEG-IFNα) plus ribavirin. Two months later, she discontinued treatment because of polydipsia, polyuria and vomiting leading to a marked dehydration. Biochemical data showed type 1 diabetes mellitus with ketoacidosis, and insulin therapy was started. The patient, who before starting PEG-IFN α plus ribavirin therapy tested negative for glutamic acid decarboxylase antibodies (GADAb) and islet cell (ICAb) antibodies, became strongly positive for both autoimmune markers. This case confirms that patients with chronic hepatitis C who do not have baseline markers of pancreatic autoimmunity may develop severe ketoacidosis during treatment with PEG-IFNα, as well as with standard IFNα. In order to avoid this complication, as no guidelines are available and the pancreatic autoimmunity markers are not routinely analysed, we suggest frequent monitoring (e.g., every one to two weeks) of glycaemic values: e.g., every one to two weeks during the first 3 months (when this complication occurs most frequently) and monthly thereafter so as to identify diabetes at an early stage and before the onset of the appearance of severe ketoacidosis, which is life-threatening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Recasens M, Aguilera E, Ampurdanes S, Sanchez Tapias JM, Simo O, Casamitjana R, Conget I (2001) Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C. Diabet Med 18:764–767

    Article  PubMed  CAS  Google Scholar 

  2. Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C (2003) Review article: type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther 18:549–558

    Article  PubMed  CAS  Google Scholar 

  3. Bosi E, Minelli R, Bazzigaluppi E, Salvi M (2001) Fulminant autoimmune type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease? Diabet Med 18:329–332

    Article  PubMed  CAS  Google Scholar 

  4. Uto H, Matsuoka H, Murata M, Okamoto, T, Miyata Y, Hori T, Ido A, Hirono S, Hayashi K, Tsubouchi H (2000) A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy. Diabetes Res Clin Pract 49:101–106

    Article  PubMed  CAS  Google Scholar 

  5. Konrad T, Zeuzem S, Vicini P, Toffolo G, Briem D, Lormann J, Hermann G, Berger A, Kusterer K, Teuber G, Cobelli C, Usadel KH (2000) Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon α. Eur J Clin Invest 30:111–121

    Article  PubMed  CAS  Google Scholar 

  6. Primo Vera J (2004) Pegylated-interferon-induced diabetes mellitus type 1 in two patients with chronic hepatitis C. Gastroenterol Hepatol 27:69

    Article  PubMed  CAS  Google Scholar 

  7. Jabr FI, Ordinario MM (2003) Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy. Am J Med 115:148–159

    Article  Google Scholar 

  8. Chen L-K, Chou Y-C, Tsait S-T, Hwang S-J, Lee S-D (2005) Hepatitis C virus infection-related type 1 diabetes mellitus. Diabet Med 22:340–343

    Article  PubMed  Google Scholar 

  9. Schories M, Peters T, Rasenack J, Reincke M (2004) Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha. Dtsch Med Wochenschr 129:1120–1124

    Article  PubMed  CAS  Google Scholar 

  10. Tohda G, Oida K, Higashi S, Hayashi T, Miyamori I (1998) Interferon alfa and development of type 1 diabetes: a case without insulin resistance. Diabetes Care 21:1774

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Tosone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tosone, G., Borgia, G., Gentile, I. et al. A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?. Acta Diabetol 44, 167–169 (2007). https://doi.org/10.1007/s00592-007-0259-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-007-0259-1

Key words

Navigation